GL1X · GenesisL1 explorer

Research workbench

Gp41-targeting HIV-1 fusion inhibitors with hook-like Ile-Asp-Leu tail

Analyse Gp41-targeting HIV-1 fusion inhibitors with hook-like Ile-Asp-Leu tail in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5HFM
Type
protein
Length
458 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.298
Source
Human immunodeficiency virus 1
Molecule
Envelope glycoprotein gp160,gp41 CHR region
UniProt
Q70626
Ligands
TAM
Pockets
1 · best druggability 0.52

Structure

x-ray diffraction · resolution 2.298 · 2 distinct chains · 84% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C, D, EEnvelope glycoprotein gp160,gp41 CHR regionprotein7782% helix, 0% strandQ70626
B, FEnvelope glycoprotein gp160,gp41 CHR regionprotein7585% helix, 0% strandQ70626

Ligands and binding sites

  • TAM · Tris(hydroxyethyl)aminomethane · ligand · 2 copies · chains B, C, D, F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12440.520.7621empty

Interfaces

9 interfaces between chains.

  • A–B · 1319 Ų buried · 9 hydrogen bonds · protein-protein
  • D–F · 1304 Ų buried · 6 hydrogen bonds · protein-protein
  • E–F · 1301 Ų buried · 9 hydrogen bonds · protein-protein
  • D–E · 1300 Ų buried · 8 hydrogen bonds · protein-protein
  • B–C · 1291 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 5HFM · GP41-targeting HIV-1 fusion inhibitors with hook-like ile-asp-leu tail · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.